Investment into future

ARTCLINE is open for new investors. Currently, the company is owned by the founders as well as the M.O.R.E Invest GmbH as the lead investor, a company of the innoveas group.

Please contact us if you like to take advantage from the fast growing field at the interface between biotechnology, intensive care medicine and medical device industry.